Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression

Shinichi Aishima, Yohsuke Kuroda, Yunosuke Nishihara, Kenichi Taguchi, Tomohiro Iguchi, Akinobu Taketomi, Yoshihiko Maehara, Masazumi Tsuneyoshi

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Aquaporin-1 (AQP-1) has been found to be important in bile formation across cell membranes of the biliary epithelium, and thus it has been suggested that AQP-1 is involved in the pathogenesis of hepatobiliary disease. To clarify the role of AQP-1 in the development of intrahepatic cholangiocarcinoma, we determined AQP-1 expression in the normal bile duct, 21 cases of biliary dysplasia, and in 112 cases of intrahepatic cholangiocarcinoma by immunohistochemical analysis. Mucus core protein 5AC expression, a poor prognostic marker of intrahepatic cholangiocarcinoma, was also assessed in intrahepatic cholangiocarcinoma cases. High (>50%) expression of AQP-1 was detected in 16% (9/58) of the normal large bile ducts examined, and in 48% (10/21) of the biliary dysplasia samples originating from large bile ducts. High (>50%), low (≤50%), and negative AQP-1 expression was observed in 46 (41%), 20 (19%), and 46 (41%) cases of intrahepatic cholangiocarcinoma, respectively. Large tumor size (>40 mm) and poorly differentiated histology were significantly more prevalent in the negative AQP-1 group than in the high AQP-1 group. Low or negative AQP-1 expression was associated with positive lymph node metastasis (P = .0001). AQP-1 expression was found to inversely correlate with that of mucus core protein 5AC, and their distributions tended to be complementary. The low and negative AQP-1 expression was an independent prognostic factor by multivariate survival analysis. We concluded that AQP-1 is up-regulated in biliary dysplasia, as compared with in the normal large bile duct, and down-regulation of AQP-1 is associated with mucin production and aggressive progression of intrahepatic cholangiocarcinoma.

Original languageEnglish
Pages (from-to)1819-1825
Number of pages7
JournalHuman Pathology
Volume38
Issue number12
DOIs
Publication statusPublished - Dec 1 2007

Fingerprint

Aquaporin 1
Cholangiocarcinoma
Mucins
Down-Regulation
Neoplasms
Bile Ducts
Mucus
Survival Analysis
Bile

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Aishima, S., Kuroda, Y., Nishihara, Y., Taguchi, K., Iguchi, T., Taketomi, A., ... Tsuneyoshi, M. (2007). Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression. Human Pathology, 38(12), 1819-1825. https://doi.org/10.1016/j.humpath.2007.04.016

Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression. / Aishima, Shinichi; Kuroda, Yohsuke; Nishihara, Yunosuke; Taguchi, Kenichi; Iguchi, Tomohiro; Taketomi, Akinobu; Maehara, Yoshihiko; Tsuneyoshi, Masazumi.

In: Human Pathology, Vol. 38, No. 12, 01.12.2007, p. 1819-1825.

Research output: Contribution to journalArticle

Aishima, S, Kuroda, Y, Nishihara, Y, Taguchi, K, Iguchi, T, Taketomi, A, Maehara, Y & Tsuneyoshi, M 2007, 'Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression', Human Pathology, vol. 38, no. 12, pp. 1819-1825. https://doi.org/10.1016/j.humpath.2007.04.016
Aishima, Shinichi ; Kuroda, Yohsuke ; Nishihara, Yunosuke ; Taguchi, Kenichi ; Iguchi, Tomohiro ; Taketomi, Akinobu ; Maehara, Yoshihiko ; Tsuneyoshi, Masazumi. / Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression. In: Human Pathology. 2007 ; Vol. 38, No. 12. pp. 1819-1825.
@article{10831e9852ff478f9b499a49734c9f74,
title = "Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression",
abstract = "Aquaporin-1 (AQP-1) has been found to be important in bile formation across cell membranes of the biliary epithelium, and thus it has been suggested that AQP-1 is involved in the pathogenesis of hepatobiliary disease. To clarify the role of AQP-1 in the development of intrahepatic cholangiocarcinoma, we determined AQP-1 expression in the normal bile duct, 21 cases of biliary dysplasia, and in 112 cases of intrahepatic cholangiocarcinoma by immunohistochemical analysis. Mucus core protein 5AC expression, a poor prognostic marker of intrahepatic cholangiocarcinoma, was also assessed in intrahepatic cholangiocarcinoma cases. High (>50{\%}) expression of AQP-1 was detected in 16{\%} (9/58) of the normal large bile ducts examined, and in 48{\%} (10/21) of the biliary dysplasia samples originating from large bile ducts. High (>50{\%}), low (≤50{\%}), and negative AQP-1 expression was observed in 46 (41{\%}), 20 (19{\%}), and 46 (41{\%}) cases of intrahepatic cholangiocarcinoma, respectively. Large tumor size (>40 mm) and poorly differentiated histology were significantly more prevalent in the negative AQP-1 group than in the high AQP-1 group. Low or negative AQP-1 expression was associated with positive lymph node metastasis (P = .0001). AQP-1 expression was found to inversely correlate with that of mucus core protein 5AC, and their distributions tended to be complementary. The low and negative AQP-1 expression was an independent prognostic factor by multivariate survival analysis. We concluded that AQP-1 is up-regulated in biliary dysplasia, as compared with in the normal large bile duct, and down-regulation of AQP-1 is associated with mucin production and aggressive progression of intrahepatic cholangiocarcinoma.",
author = "Shinichi Aishima and Yohsuke Kuroda and Yunosuke Nishihara and Kenichi Taguchi and Tomohiro Iguchi and Akinobu Taketomi and Yoshihiko Maehara and Masazumi Tsuneyoshi",
year = "2007",
month = "12",
day = "1",
doi = "10.1016/j.humpath.2007.04.016",
language = "English",
volume = "38",
pages = "1819--1825",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "12",

}

TY - JOUR

T1 - Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression

AU - Aishima, Shinichi

AU - Kuroda, Yohsuke

AU - Nishihara, Yunosuke

AU - Taguchi, Kenichi

AU - Iguchi, Tomohiro

AU - Taketomi, Akinobu

AU - Maehara, Yoshihiko

AU - Tsuneyoshi, Masazumi

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Aquaporin-1 (AQP-1) has been found to be important in bile formation across cell membranes of the biliary epithelium, and thus it has been suggested that AQP-1 is involved in the pathogenesis of hepatobiliary disease. To clarify the role of AQP-1 in the development of intrahepatic cholangiocarcinoma, we determined AQP-1 expression in the normal bile duct, 21 cases of biliary dysplasia, and in 112 cases of intrahepatic cholangiocarcinoma by immunohistochemical analysis. Mucus core protein 5AC expression, a poor prognostic marker of intrahepatic cholangiocarcinoma, was also assessed in intrahepatic cholangiocarcinoma cases. High (>50%) expression of AQP-1 was detected in 16% (9/58) of the normal large bile ducts examined, and in 48% (10/21) of the biliary dysplasia samples originating from large bile ducts. High (>50%), low (≤50%), and negative AQP-1 expression was observed in 46 (41%), 20 (19%), and 46 (41%) cases of intrahepatic cholangiocarcinoma, respectively. Large tumor size (>40 mm) and poorly differentiated histology were significantly more prevalent in the negative AQP-1 group than in the high AQP-1 group. Low or negative AQP-1 expression was associated with positive lymph node metastasis (P = .0001). AQP-1 expression was found to inversely correlate with that of mucus core protein 5AC, and their distributions tended to be complementary. The low and negative AQP-1 expression was an independent prognostic factor by multivariate survival analysis. We concluded that AQP-1 is up-regulated in biliary dysplasia, as compared with in the normal large bile duct, and down-regulation of AQP-1 is associated with mucin production and aggressive progression of intrahepatic cholangiocarcinoma.

AB - Aquaporin-1 (AQP-1) has been found to be important in bile formation across cell membranes of the biliary epithelium, and thus it has been suggested that AQP-1 is involved in the pathogenesis of hepatobiliary disease. To clarify the role of AQP-1 in the development of intrahepatic cholangiocarcinoma, we determined AQP-1 expression in the normal bile duct, 21 cases of biliary dysplasia, and in 112 cases of intrahepatic cholangiocarcinoma by immunohistochemical analysis. Mucus core protein 5AC expression, a poor prognostic marker of intrahepatic cholangiocarcinoma, was also assessed in intrahepatic cholangiocarcinoma cases. High (>50%) expression of AQP-1 was detected in 16% (9/58) of the normal large bile ducts examined, and in 48% (10/21) of the biliary dysplasia samples originating from large bile ducts. High (>50%), low (≤50%), and negative AQP-1 expression was observed in 46 (41%), 20 (19%), and 46 (41%) cases of intrahepatic cholangiocarcinoma, respectively. Large tumor size (>40 mm) and poorly differentiated histology were significantly more prevalent in the negative AQP-1 group than in the high AQP-1 group. Low or negative AQP-1 expression was associated with positive lymph node metastasis (P = .0001). AQP-1 expression was found to inversely correlate with that of mucus core protein 5AC, and their distributions tended to be complementary. The low and negative AQP-1 expression was an independent prognostic factor by multivariate survival analysis. We concluded that AQP-1 is up-regulated in biliary dysplasia, as compared with in the normal large bile duct, and down-regulation of AQP-1 is associated with mucin production and aggressive progression of intrahepatic cholangiocarcinoma.

UR - http://www.scopus.com/inward/record.url?scp=36549011726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36549011726&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2007.04.016

DO - 10.1016/j.humpath.2007.04.016

M3 - Article

VL - 38

SP - 1819

EP - 1825

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 12

ER -